Female factor in the development of cholelithiasis
- Autores: Dzhulay G.S.1, Dzhulay T.E.1
-
Afiliações:
- Tver State Medical University of the Ministry of Healthcare of Russia
- Edição: Volume 11, Nº 5 (2025)
- Páginas: 93-99
- Seção: REVIEWS
- URL: https://journals.eco-vector.com/2412-4036/article/view/689015
- DOI: https://doi.org/10.18565/therapy.2025.5.93-99
- ID: 689015
Citar
Texto integral



Resumo
Article presents data from the study of domestic and foreign literature devoted to the pathogenetic role of female fertility factor in the development of cholelithiasis, with the aim of finding opportunities for preventive action at its development in females with a family predisposition to cholelithiasis and dyshormonosis in the sex hormone system. When choosing a method of contraception and hormone replacement therapy for such female patients, information about hereditary burden of cholelithiasis should be taken into account, instrumental visualization of the biliary tract should be carried out to exclude bile sludge and asymptomatic stone carriage, the possibility of litholytic therapy should be agreed with a gastroenterologist.
Palavras-chave
Texto integral

Sobre autores
Galina Dzhulay
Tver State Medical University of the Ministry of Healthcare of Russia
Autor responsável pela correspondência
Email: djoulai@mail.ru
ORCID ID: 0000-0002-7687-8157
Código SPIN: 4220-7478
MD, Dr. Sci. (Medicine), professor, head of the Department of faculty therapy
Rússia, TverTatiana Dzhulay
Tver State Medical University of the Ministry of Healthcare of Russia
Email: tdzhulay@mail.ru
ORCID ID: 0000-0001-7926-6749
Código SPIN: 5540-8528
MD, PhD (Medicine), associate professor, associate professor of the Department of faculty therapy
Rússia, TverBibliografia
- Шаталов А.Д., Хацко В.В., Дудин А.М., Мамисашвили З.С., Страшко Е.Н. Современные представления об этиологии и патогенезе желчнокаменной болезни. Вестник гигиены и эпидемиологии. 2022;26(4):416–422. [Shatalov AD, Khatsko VV, Dudin AM, Mamisashvili ZS, Strashko EN. Modern concepts of the etiology and pathogenesis of cholelithiasis. Vestnik gigieny i epidemiologii = Bulletin of Hygiene and Epidemiology. 2022;26(4):416–422 (In Russ.)]. EDN: UAQZLS.
- Вахрушев Я.М., Хохлачева Н.А. Желчнокаменная болезнь: эпидемиология, факторы риска, особенности клинического течения, профилактика. Архивъ внутренней медицины. 2016;6(3):30–35. [Vakhrushev YaM, Khokhlacheva NA. Gallstone disease: Epidemiology, risk factors, clinical course features, prevention. Arkhiv vnutrenney meditsiny = Archive of Internal Medicine. 2016;6(3):30–35 (In Russ.)]. EDN: VZTUIL. https://doi.org/10.20514/2226-6704-2016-6-3-30-35
- Di Ciaula A, Wang DQ-H, Portincasa P. An update on the pathogenesis of cholesterol gallstone disease. Curr Opin Gastroenterol. 2018;34(2):71–80. PMID: 29283909. PMCID: PMC8118137. https://doi.org/10.1097/MOG.0000000000000423
- Lammert F, Gurusamy K, Ko CW, Miquel J-F, Méndez-Sánchez N, Portincasa P et al. Gallstones. Nat Rev Dis Primers. 2016;2:16024. PMID: 27121416. https://doi.org/10.1038/nrdp.2016.24
- Штыгашева О.В., Агеева Е.С., Чмыхало С.В. Консерватизм и дивергенция в семиотике желчнокаменной болезни. Экспериментальная и клиническая гастроэнтерология. 2022;(8):63–69. [Shtygasheva OV, Ageeva ES, Chmykhalo SV. Conservatism and divergence in the semiotics of cholelithiasis. Eksperimental’naya i klinicheskaya gastroenterologiya = Experimental and Clinical Gastroenterology. 2022;(8):63–69 (In Russ.)]. EDN: VMFRKX. https://doi.org/10.31146/1682-8658-ecg-204-8-63-69
- Shabanzadeh DM, Sørensen LT, Jørgensen T. Determinants for gallstone formation - a new data cohort study and a systematic review with meta-analysis. Scand J Gastroenterol. 2016;51(10):1239–48. PMID: 27232657. https://doi.org/10.1080/00365521.2016.1182583
- Суздалкина В.М., Свиркина К.В., Мокашева Е.Н., Мокашева Ек.Н. Гендерные особенности заболеваний желудочно-кишечного тракта. European Journal of Natural History. 2022;(2):65–70. [Suzdalkina VM, Svirkina KV, Mokasheva EN, Mokasheva EkN. Gender characteristics of gastrointestinal diseases. European Journal of Natural History. 2022;(2):65–70 (In Russ.)]. EDN: ADAYSG.
- Успенская Ю.Б., Шептулин А.А. Особенности патогенеза, диагностики и лечения желчнокаменной болезни при беременности. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2017;27(2):111–116. [Uspenskaya YuB, Sheptulin AA. Features of pathogenesis, diagnosis and treatment of cholelithiasis during pregnancy. Rossiiskiy zhurnal gastroenterologii, gepatologii, koloproktologii = Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2017;27(2):111–116 (In Russ.)]. EDN: YKVHMZ. https://doi.org/10.22416/1382-4376-2017-27-2-111-116
- Wang HH, Liu M, Clegg DJ, Portincasa P, Wang DQ-H. New insights into the molecular mechanisms underlying effects of estrogen on cholesterol gallstone formation. Biochim Biophys Acta. 2009;1791(11):1037–47. PMID: 19589396. PMCID: PMC2756670. https://doi.org/10.1016/j.bbalip.2009.06.006
- Hay JE. Liver disease in pregnancy. Hepatology. 2008;47(3):1067–76. PMID: 18265410. https://doi.org/10.1002/hep.22130
- Gruber CJ, Tschugguel W, Schneeberger C, Huber JC. Production and actions of estrogens. N Engl J Med. 2002;346(5):340–52. PMID: 11821512. https://doi.org/10.1056/NEJMra000471
- Novacek G. Gender and gallstone disease. Wien Med Wochenschr. 2006;156(19–20):527–33. PMID: 17103289. https://doi.org/10.1007/s10354-006-0346-x
- DeLeon C, Wang DQ-H, Arnatt CK. G Protein-coupled estrogen receptor, GPER1, offers a novel target for the treatment ofdigestive diseases. Front Endocrinol (Lausanne). 2020;11:578536. PMID: 33281743. PMCID: PMC7689683. https://doi.org/10.3389/fendo.2020.578536
- Успенская Ю.Б. Современные возможности профилактики и лечения желчнокаменной болезни в период беременности. Фарматека. 2016;(12):20–28. [Uspenskaya YuB. Modern possibilities of prevention and treatment of cholelithiasis during pregnancy. Farmateka. 2016;(12):20–28 (In Russ.)]. EDN: WWVQHB.
- Balakrishnan G, Iqbal T, Uppinakudru G, Fernandes R, Bangera S, Dutt RA. The impact of lifestyle stressors, menstrual pattern, and cardiometabolic risk factors on young females with cholelithiasis. J Educ Health Promot. 2022;11:255. PMID: 36325235. PMCID: PMC9621381. https://doi.org/10.4103/jehp.jehp_1767_21
- Yuan S, Wang L, Sun J, Yu L, Zhou X, Yang J et al. Genetically predicted sex hormone levels and health outcomes: Phenome-wide Mendelian randomization investigation. Int J Epidemiol. 2022;51(6):1931–42. PMID: 35218343. PMCID: PMC9749729. https://doi.org/10.1093/ije/dyac036
- de Bari O, Wang TY, Liu M, Paik C-N, Portincasa P, Wang DQ-H. Cholesterol cholelithiasis in pregnant women: pathogenesis, prevention and treatment. Ann Hepatol. 2014;13(6):728–45. PMID: 25332259.
- Ko CW, Beresford SAA, Schulte SJ, Matsumoto AM, Lee SP. Incidence, natural history, and risk factors for biliary sludge and stones during pregnancy. Hepatology. 2005;41(2):359–65. PMID: 15660385. https://doi.org/10.1002/hep.20534
- Грицева С.В., Денисов М.Ю. Изучение состояния органов билиарного тракта при невынашиваемости беременности. Материалы V Международного конгресса «Новые технологии в акушерстве, гинекологии, перинатологии и репродуктивной медицине». Новосибирск: Новосибирский национальный исследовательский государственный университет. 2021:121–128. [Gritseva SV, Denisov MYu. Study of the state of the biliary tract organs in case of miscarriage. Proceedings of the V International Congress “New Technologies in Obstetrics, Gynecology, Perinatology and Reproductive Medicine”. Novosibirsk: Novosibirsk National Research State University. 2021:121–128 (In Russ.)]. EDN: NBVFPY.
- Salari N, Hasheminezhad R, Heidarisharaf P, Khaleghi AA, Azizi AH, Shohaimi S, Mohammadi M. The global prevalence of gallstones in pregnancy: A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol X. 2023;19:100237. PMID: 37711873. PMCID: PMC10497987. https://doi.org/10.1016/j.eurox.2023.100237
- Kilander C, Lagergren J, Konings P, Sadr-Azodi O, Brusselaers N. Menopausal hormone therapy and biliary tract cancer: A population-based matched cohort study in Sweden. Acta Oncol. 2019;58(3):290–95. PMID: 30656997. https://doi.org/10.1080/0284186X.2018.1549367
- Yuk J-S, Park JY. Menopausal hormone therapy increases the risk of gallstones: Health Insurance Database in South Korea (HISK)-based cohort study. PLoS One. 2023;18(12):e0294356. PMID: 38048308. PMCID: PMC10695378. https://doi.org/10.1371/journal.pone.0294356
- Dhiman RK, Chawla YK. Hormone replacement therapy and gallstone disease: A real association. Digestion. 2008;77(1):1–3. PMID: 18212500. https://doi.org/10.1159/000113896
- Jackson SS, Graubard BI, Gabbi C, Koshiol J. Association with menopausal hormone therapy and asymptomatic gallstones in US women in the third National Health and Nutrition Examination Study. Sci Rep. 2024;14(1):191. PMID: 38168135. PMCID: PMC10761940. https://doi.org/10.1038/s41598-023-50509-2
- Zhang G-Q, Chen J-L, Luo Y, Mathur MB, Anagnostis P, Nurmatov U et al. Menopausal hormone therapy and women’s health: An umbrella review. PLoS Med. 2021;18(8):e1003731. PMID: 34339416. PMCID: PMC8366967. https://doi.org/10.1371/journal.pmed.1003731
- Reshetnyak VI. Concept of the pathogenesis and treatment of cholelithiasis. World J Hepatol. 2012;4(2):18–34. PMID: 22400083. PMCID: PMC3295849. https://doi.org/10.4254/wjh.v4.i2.18
- Khan MK, Jalil MA, Khan MS. Oral contraceptives in gall stone diseases. Mymensingh Med J. 2007;16(2 Suppl):S40–45. PMID: 17917630.
- Ali A, Perveen S, Khan I, Ahmed T, Nawaz A, Rab A. Symptomatic gallstones in young patients under the age of 30 years. Cureus. 2021;13(11):e19894. PMID: 34976505. PMCID: PMC8712198. https://doi.org/10.7759/cureus.19894
- Abu-Eshy SA, Mahfouz AA, Badr A, El Gamal MN, Al-Shehri MY, Salati MI, Rabie ME. Prevalence and risk factors of gallstone disease in a high altitude Saudi population. East Mediterr Health J. 2007;13(4):794–802. PMID: 17955761.
- Wang S, Wang Y, Xu J, Chen Y. Is the oral contraceptive or hormone replacement therapy a risk factor for cholelithiasis: A systematic review and meta-analysis. Medicine (Baltimore). 2017;96(14):e6556. PMID: 28383429. PMCID: PMC5411213. https://doi.org/10.1097/MD.0000000000006556
- Harden K. Letter: Iatrogenic gall stones. Br Med J. 1976;1(6017):1074. PMID: 1268565. PMCID: PMC1639856. https://doi.org/10.1136/bmj.1.6017.1074-c
- Tirthani E, Said M, Neupane B, Quartuccio M. An unusual case of the “terrible triad” in a transgender woman. Cureus. 2021;13(8):e16869. PMID: 34513444. PMCID: PMC8411995. https://doi.org/10.7759/cureus.16869
- Tabernacki T, Loria M, Rhodes S, Pope R, Gupta S, Banik S, Mishra K. Gallbladder disease in transgender individuals: Associations with gender-affirming hormone therapy. Int J Transgend Health. 2023;25(4): 896–910. PMID: 39465080. PMCID: PMC11500541. https://doi.org/10.1080/26895269.2023.2283532
- Deutsch MB, Bhakri V, Kubicek K. Effects of cross-sex hormone treatment on transgender women and men. Obstet Gynecol. 2015;125(3):605–10. PMID: 25730222. PMCID: PMC4442681. https://doi.org/10.1097/AOG.0000000000000692
- Littlefield A, Lenahan C. Cholelithiasis: Presentation and management. J Midwifery Womens Health. 2019;64(3):289–97. PMID: 30908805. https://doi.org/10.1111/jmwh.12959
- Клинические рекомендации. Желчнокаменная болезнь. Общероссийская общественная организация «Российское общество хирургов», Российская гастроэнтерологическая ассоциация, ассоциация «Эндоскопическое общество «РЭндО». Рубрикатор клинических рекомендаций Минздрава России. 2020. ID: 877_1. Доступ: https://cr.minzdrav.gov.ru/preview-cr/877_1 (дата обращения – 16.06.2025). [Clinical guidelines. Cholelithiasis. Russian Society of Surgeons, Russian Gastroenterological Association, Endoscopic Society “REnDO”. Rubricator of clinical guidelines of the Ministry of Healthcare of Russia. 2020. ID: 877_1. URL: https://cr.minzdrav.gov.ru/preview-cr/877_1 (date of access – 16.06.2025) (In Russ.)].
- Di Ciaula A, Wang DQH, Wang HH, Bonfrate L, Portincasa P. Targets for current pharmacologic therapy in cholesterol gallstone disease. Gastroenterol Clin North Am. 2010;39(2):245–64,viii–ix. PMID: 20478485. PMCID: PMC2915454. https://doi.org/10.1016/j.gtc.2010.02.005
- Stein A, Hermoni D, Elis A, Konikoff FM. Effect of ezetimibe on the prevalence of cholelithiasis. World J Gastroenterol. 2012;18(40):5789–92. PMID: 23155321. PMCID: PMC3484349. https://doi.org/10.3748/wjg.v18.i40.5789
- Guarino MPL, Cocca S, Altomare A, Emerenziani S, Cicala M. Ursodeoxycholic acid therapy in gallbladder disease, a story not yet completed. World J Gastroenterol. 2013;19(31):5029–34. PMID: 23964136. PMCID: PMC3746374. https://doi.org/10.3748/wjg.v19.i31.5029
Arquivos suplementares
